Cargando…

The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is a progressive airway disease characterised by neutrophilic airway inflammation or bronchitis. Neutrophilic bronchitis is associated with both bacterial colonisation and lung function decline and is common in exacerbations of COPD. Despite c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpson, Jodie L., Powell, Heather, Baines, Katherine J., Milne, David, Coxson, Harvey O., Hansbro, Philip M., Gibson, Peter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141795/ https://www.ncbi.nlm.nih.gov/pubmed/25148049 http://dx.doi.org/10.1371/journal.pone.0105609

Ejemplares similares

Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
por: Baines, Katherine J., et al.
Publicado: (2018)

Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
por: Simpson, Jodie L., et al.
Publicado: (2013)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
por: Siva, Roshan, et al.
Publicado: (2014)

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
por: Gibson, Peter G., et al.
Publicado: (2019)

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
por: Segal, Leopoldo N, et al.
Publicado: (2017)

Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
por: Negewo, Netsanet A, et al.
Publicado: (2016)

Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
por: van Beers, Martijn, et al.
Publicado: (2021)

Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression
por: Lokwani, Ravi, et al.
Publicado: (2019)

The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2016)

Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial
por: Stokholm, Jakob, et al.
Publicado: (2016)

Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial
por: Pavlinac, Patricia B, et al.
Publicado: (2021)

Azithromycin vs. Placebo for the Clinical Outcome in Campylobacter concisus Diarrhoea in Adults: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
por: Nielsen, Hans Linde, et al.
Publicado: (2016)

Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study
por: Pragman, Alexa A, et al.
Publicado: (2021)

Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial)
por: Pavlinac, Patricia B, et al.
Publicado: (2017)

Acute Dietary Nitrate Supplementation and Exercise Performance in COPD: A Double-Blind, Placebo-Controlled, Randomised Controlled Pilot Study
por: Curtis, Katrina J., et al.
Publicado: (2015)

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
por: Singh, Dave, et al.
Publicado: (2022)

Effect of acetazolamide on pulmonary vascular haemodynamics in patients with COPD going to altitude: a randomised, placebo-controlled, double-blind trial
por: Lichtblau, Mona, et al.
Publicado: (2023)

Sputum colour can identify patients with neutrophilic inflammation in asthma
por: Pabreja, Kavita, et al.
Publicado: (2017)

Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide
por: DeBoer, Mark Daniel, et al.
Publicado: (2018)

Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19
por: Omrani, Ali S., et al.
Publicado: (2020)

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
por: Dutta, Prosenjit, et al.
Publicado: (2019)

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
por: Willcox, Merlin L., et al.
Publicado: (2023)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

Severity of Lung Function Impairment Drives Transcriptional Phenotypes of COPD and Relates to Immune and Metabolic Processes
por: Negewo, Netsanet A, et al.
Publicado: (2023)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
por: Fukuchi, Yoshinosuke, et al.
Publicado: (2016)

Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial
por: Wei, Shaodong, et al.
Publicado: (2018)

Trimethoprim-sulfamethoxazole Versus Azithromycin for the Treatment of Undifferentiated Febrile Illness in Nepal: A Double-blind, Randomized, Placebo-controlled Trial
por: Giri, Abhishek, et al.
Publicado: (2020)

Haemophilus influenzae Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease
por: Essilfie, Ama-Tawiah, et al.
Publicado: (2011)

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD
por: Martin, Allison, et al.
Publicado: (2021)

Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
por: Goyal, Vikas, et al.
Publicado: (2019)

Airway monocyte modulation relates to tumour necrosis factor dysregulation in neutrophilic asthma
por: Niessen, Natalie M., et al.
Publicado: (2021)

Creatine supplementation and physical training in patients with COPD: A double blind, placebo-controlled study
por: Faager, Gun, et al.
Publicado: (2006)

Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
por: Li, Yan, et al.
Publicado: (2021)

Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial
por: Madanitsa, Mwayiwawo, et al.
Publicado: (2023)

Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
por: Worth, Heinrich, et al.
Publicado: (2009)

Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial
por: Hu, Xiao-Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_an80vnosmrcvusf9017f64asjb